Vitalhub Corp. (TSE:VHI) Given Average Recommendation of "Buy" by Brokerages

Key Points

• Vitalhub Corp. has received a consensus recommendation of "Buy" from seven brokerages, with an average 12-month target price of C$14.08.
• Recent analyses from TD Securities and other financial institutions have increased price targets for the stock, with TD raising it from C$15.00 to C$16.00.
• Insider selling occurred recently, with Director Danny Matlow selling 150,000 shares, indicating a 22.39% decrease in his position in the company.

Shares of Vitalhub Corp. (TSE:VHI - Get Free Report) have received a consensus recommendation of "Buy" from the seven brokerages that are currently covering the stock, Marketbeat.com reports. Six analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is C$14.08.

A number of brokerages have weighed in on VHI. TD Securities boosted their price target on Vitalhub from C$15.00 to C$16.00 and gave the stock a "buy" rating in a research report on Monday, August 11th. National Bank Financial raised Vitalhub to a "strong-buy" rating in a report on Monday, June 9th. Scotiabank increased their price target on Vitalhub from C$14.00 to C$14.50 and gave the company an "outperform" rating in a research note on Friday, June 20th. Raymond James Financial increased their price objective on shares of Vitalhub from C$14.50 to C$15.00 and gave the company an "outperform" rating in a research report on Tuesday, August 12th. Finally, National Bankshares set a C$16.00 target price on shares of Vitalhub and gave the stock an "outperform" rating in a research note on Thursday, August 21st.

Vitalhub Price Performance

Vitalhub stock opened at C$11.02 on Thursday. The company's 50-day moving average is C$12.61 and its 200-day moving average is C$11.07. The firm has a market capitalization of C$692.39 million, a PE ratio of 137.75, a P/E/G ratio of 1.18 and a beta of 0.93. Vitalhub has a fifty-two week low of C$8.30 and a fifty-two week high of C$14.64.

Insider Buying and Selling

In other Vitalhub news, Director Danny Matlow sold 150,000 shares of the firm's stock in a transaction on Thursday, August 28th. The stock was sold at an average price of C$12.75, for a total transaction of C$1,912,500.00. Following the transaction, the director owned 520,001 shares in the company, valued at C$6,630,012.75. This trade represents a 22.39% decrease in their position. Also, Director Steve Garrington sold 20,000 shares of the company's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of C$12.90, for a total transaction of C$258,000.00. Following the sale, the director directly owned 60,000 shares of the company's stock, valued at C$774,000. This represents a 25.00% decrease in their position. 18.57% of the stock is currently owned by company insiders.

About Vitalhub

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.